NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $275 | -15.9% | 106 | +32.5% | 0.00% | – |
Q1 2023 | $327 | – | 80 | +263.6% | 0.00% | – |
Q2 2022 | $0 | – | 22 | +4.8% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 21 | -16.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 25 | -7.4% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 27 | -35.7% | 0.00% | – |
Q1 2020 | $1,000 | – | 42 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |